Marimed director exercises 75,000 RSUs into shares

MARIMED INC. director David R. Allen exercised restricted stock units into common shares.

Rhea-AI Filing Summary

MARIMED INC. director David R. Allen exercised restricted stock units into common shares. He converted 75,000 RSUs into 75,000 shares of common stock at a stated price of $0.0000 per share. After this transaction, he holds 551,144 common shares directly. The RSUs were originally granted on June 12, 2025 and have now been fully settled, with no units remaining under that grant.

Insights

Equity Compensation Analyst

Routine RSU vesting converts into common shares with no sale.

Director David R. Allen exercised 75,000 Restricted Stock Units (RSUs) into an equal number of MARIMED INC. common shares. The transaction code M and description indicate an exercise or conversion of a derivative security, not an open-market purchase or sale.

The filing shows 551,144 common shares held directly after the transaction, suggesting this is part of ongoing equity compensation rather than a position exit. Footnotes clarify that RSUs convert one-for-one into common stock and that this specific June 12, 2025 grant is now fully exhausted.

Insider Trade Summary

75,000 shares exercised/converted

Exercise 2 txns

Insider Allen David R

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units (RSU)	75,000	$0.00	$0.00
Exercise	Common stock	75,000	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units (RSU) — 0 contracts (Direct); Common stock — 551,144 shares (Direct)

Footnotes (2)

1. F1. RSUs convert to shares of common stock on a one-for-one basis.
2. F2. The RSUs were granted on June 12, 2025; there are no RSUs remaining under this grant in accordance with the terms of the award agreement between the Issuer and the Reporting Person.

Key Figures

RSUs exercised: 75,000 shares Common shares after transaction: 551,144 shares RSU conversion ratio: 1:1 +2 more

5 metrics

RSUs exercised 75,000 shares Restricted Stock Units converted to common stock

Common shares after transaction 551,144 shares Total direct holdings following RSU conversion

RSU conversion ratio 1:1 RSUs convert to common stock on a one-for-one basis

RSU grant date June 12, 2025 Original grant date of the exercised RSUs

Exercise transactions 1 transaction, 75,000 shares Exercise or conversion of derivative security (code M)

Key Terms

Restricted Stock Units (RSU), derivative security, one-for-one basis, award agreement

4 terms

Restricted Stock Units (RSU) financial

"security_title: "Restricted Stock Units (RSU)""

derivative security financial

"transaction_code_description: "Exercise or conversion of derivative security""

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

one-for-one basis financial

"RSUs convert to shares of common stock on a one-for-one basis."

award agreement financial

"in accordance with the terms of the award agreement between the Issuer and the Reporting Person."

An award agreement is a legal contract that spells out the terms of a pay or equity grant—such as stock options, restricted shares, or cash bonuses—given to an employee, director or consultant. It describes what is being granted, any conditions for keeping it (for example, earning it over time or meeting performance targets), and what happens if the person leaves or breaks rules. Investors care because these agreements affect company costs, potential share dilution and how executives are motivated and rewarded.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did MARIMED INC. director David R. Allen report in this Form 4 for MRMD?

David R. Allen reported exercising 75,000 Restricted Stock Units into 75,000 shares of MARIMED INC. common stock. This is an equity compensation conversion, not an open-market trade, and reflects vesting of a prior RSU grant into directly held shares.

How many MARIMED INC. (MRMD) shares does David R. Allen hold after this transaction?

After the RSU conversion, David R. Allen holds 551,144 shares of MARIMED INC. common stock directly. This figure, reported in the Form 4, shows his updated post-transaction ownership position as a director of the company.

Did David R. Allen buy or sell MARIMED INC. (MRMD) shares on the market?

The filing shows no open-market buys or sells. Instead, Allen exercised 75,000 Restricted Stock Units into common shares, a compensation-related conversion classified under code M, which records derivative exercises rather than discretionary market trading activity.

What are the terms of the RSUs reported in this MARIMED INC. Form 4?

The RSUs convert into common stock on a one-for-one basis, so 75,000 RSUs became 75,000 shares. Footnotes state the RSUs were granted on June 12, 2025, and that no RSUs remain under this grant after the reported conversion.

Does this MARIMED INC. (MRMD) Form 4 show any remaining derivative awards for David R. Allen?

The derivative section reports zero RSUs remaining from the June 12, 2025 grant, and the derivative summary is empty. This indicates that particular RSU grant has been fully exercised into common shares with no leftover units from that award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 04:42 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Allen David R

(Last) (First) (Middle)

C/O MARIMED INC.

10 OCEANA WAY

(Street)

NORWOOD MASSACHUSETTS 02062

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	06/12/2026		M		75,000	A	$0(1)	551,144	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (RSU)	(1)	06/12/2026		M			75,000	(2)	(2)	Common Stock, par value $.001 per share	75,000	$0	0	D

Explanation of Responses:

1. RSUs convert to shares of common stock on a one-for-one basis.

2. The RSUs were granted on June 12, 2025; there are no RSUs remaining under this grant in accordance with the terms of the award agreement between the Issuer and the Reporting Person.

Remarks:

	/s/ David R. Allen	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)